Skip to main content
Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
9,155.00
+264.00 (2.97%)
At close: Dec 4, 2025

TLV:TEVA Revenue

Teva Pharmaceutical Industries had revenue of $4.48B USD in the quarter ending September 30, 2025, with 3.42% growth. This brings the company's revenue in the last twelve months to $16.78B, up 0.02% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.

Revenue (ttm)
$16.78B
Revenue Growth
+0.02%
P/S Ratio
1.90
Revenue / Employee
$470.10K
Employees
35,686
Market Cap
105.71B ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Danel (Adir Yeoshua) 2.87B
Kamada 578.74M
BrainsWay 162.56M
Bait Bakfar 107.78M
SofWave Medical 255.13M
Ilex Medical 915.05M
Novolog (Pharm-Up 1966) 1.97B
InterCure 243.12M
Revenue Rankings

Teva Pharmaceutical Industries News

More News